Premium Reports
Epic Pharmacy Solutions 2020

Epic Pharmacy Solutions 2020
What Progress Has Epic Made With Medication Inventory and IV Workflow Management?

October 22, 2020 | Read Time: 5  minutes

Current Time Inside Cache Tag Helper: 2/24/2021 10:30:58 PM and Model.reportId = 1703

Despite pressure to take an Epic-first approach to software decisions, many pharmacies at Epic organizations have held on to third-party products due to the relative immaturity of some of Epic’s more recently developed pharmacy solutions. However, Epic has put significant focus on broad pharmacy development (the only enterprise EMR vendor to have done so), and customers want to know—is it time to switch? To answer this question, this report explores medication inventory management (MIM) and IV workflow management—the two areas where Epic has focused much of their development efforts—to validate what capabilities these modules deliver and where gaps still exist.

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Current Time Inside Cache Tag Helper: 2/24/2021 10:30:58 PM and Model.reportId = 1703

Key Findings

  1. Overall Progress Report: Technology Development Slow and Steady; Workflows and Optimization Left to the Customer
  2. Medication Inventory Management (Willow Inventory)
    • Willow Tracks In-Scope Medications Well; Gaps Remain with Reporting
    • Inventory Data from Third-Party Sources Often Incomplete
  3. IV Workflow Management (IV Dispense Prep)
    • IV Dispense Prep Meets Core Needs; Lacks More Advanced Capabilities Out of the Box
  4. Epic Pharmacy Ecosystem
    • Epic’s Pharmacy Functionality Delivers Breadth but Not Depth
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.